Publications
Publications (Past Five Years):
Bowyer SL, Roettcher PA, Higgins GG, Moore TL, Pepmueller PH, Elwood C, et al: Health status of patients with juvenile rheumatoid arthritis one and five years after diagnosis. J Rheumatol 30: 394-400, 2003
Lee DH, Daud U, Wipfl J, Pepmueller, PH, Davitt BV, Moore TL: The decreasing prevalence of uveitis associated with juvenile rheumatoid arthritis: do NSAIDs play a role. J Clin Rheumatol 9: 151-155, 2003
Perlman H, Nguyen N, Liu H, Eslick J, Esser S, Walsh K, Moore TL, Pope RM: Rheumatoid arthritis synovial fluid macrophages express decreased TRAIL R2 and increased decay receptor TRAIL R3. Arthritis Rheum 48: 3096-3101, 2003
Kamat SS, Pepmueller PH, Moore TL: Triplets with systemic lupus erythematosus. Arthritis Rheum 48: 3176-3180, 2003
Moore TL, Ince DO, Ince A: Temporomandibular joint disease in children with juvenile idiopathic arthritis. Pediatr Rheumatol 1: 250-260, 2003
Bradley K, Scatizzi JC, Bickel E, Albec L, Gorges L, Wolinsky SM, Kunstman KJ, Fiore S, Shamiyeh E, Koch AE, Firestein GS, Pope RM, Moore TL, Han J, Perlman H: Retinoblastoma suppression of matrix metalloproteinase-1, but not IL-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 50: 78-87, 2004
Dorsey RR, Andresen EM, Moore TL: Health-related quality of life and support group attendance for patients with systemic lupus erythematosus. J Clin Rheumatol 10: 6-9, 2004
Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL: Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol 31: 1829-1833, 2004
Yazici Y, Erkan D, Ince A, Nesher G, Kural E, Seyahi N, Moore TL: Behçet’s disease: Does lack of knowledge result in underdiagnosis? Clin Exp Rheumatol 22: 81-82, 2004
Overton SD, Hong JJ, Moore TL, Johnson FE: Autoamputation in a patient with cryoglobulinemia. J Rheumatol 31: 2088-2089, 2004
Dorsey RR, Andresen EM, Moore TL: NF-kB regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from TNFa mediated apoptosis. Arthritis Rheum 50: 3844-3855, 2004
Low JM, Moore TL: A role for the complement system in rheumatoid arthritis. Curr Pharm Design 11: 655-670, 2005
Moore TL: Pathogenesis and diagnosis of viral arthritis. Up to Date Rheumatol 13: 1-5, 2005
Moore TL: Specific viruses that cause arthritis. Up to Date Rheumatol 13: 1-11, 2005
Temprano KK, Bandlamudi R, Moore TL: Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35: 112-121, 2005
Moore TL: Diseases of the joints. In “Principles and Practice of Geriatric Medicine”, (eds) MSJ Pathy, AJ Sinclair, JE Morley (4th Edition) pp 1347-1353, 2006
Nesher G, Breuer SN, Dahan SO, Temprano KK, Moore TL, Hersh AL, Alberton SN: Lupus pancreatitis. Semin Arthritis Rheum 35: 260-267, 2006
Zulian F, Athreya BH, Laxer R, et al, Moore TL, et al: Juvenile localized scleroderma: clinical and epidemiological features in 727 children. An international study. Rheumatology 45: 614-620, 2006
Scatizzi JC, Hutcheson J, Bickel E, Moore TL, Haines GK, Perlman H: p21 Cip1 is required for the development of monoctyes and their response to serum transfer-induced arthritis. Am J Pathol 168: 1531-1541, 2006
Beers WH, Ince A, Moore TL: Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 35: 355-359, 2006
Goldbach-Mansky R, Dailey N. Canna S, et al, Moore TL, et al, Kastner DL: Neonatal onset multisystem inflammatory disease- a disorder of IL-1 signaling responsive to anakinra. N Engl J Med 355: 581-592, 2006
Chauhan AK, Moore TL: Presence of plasma complement regulatory proteins clusterin (ApoJ) and vitronectin (S40) on circulating immune complexes. Clin Exp Immunol 145: 398-406, 2006
Low JM, Chauhan AK, Moore TL: Abnormal kappa to lambda light chain ratio in circulating immune complexes from patients with juvenile idiopathic arthritis as a marker for B cell activity. Scand J Immunol 65: 76-83, 2007
Moore TL: Juvenile idiopathic arthritis. In: “Conn’s Current Therapy”, (ed) RE Rakel, ET Bope, pp 1137-1140, 2007
Moore TL, Syed RH: Specific viruses that cause arthritis -1 and 11. Up to Date Rheumatol 15: 1-18, 2007
Temprano KK, Moore TL: Evaluation of rheumatic conditions. In: “First Exposure” to Internal Medicine: Ambulatory Medicine, (eds) AR Hoellen, CH Griffith, CA Feddock, SA Haist, TH Loftus (1st Edition) pp 318-326, 2007
Gilliam BE, Wolff AE, Moore TL: Partial C4 deficiency in juvenile idiopathic arthritis patients. J Clinical Rheumatol 13: 256-260, 2007
Syed RH, Moore TL: Methylphenidate and dextroamphetamine induced peripheral vasculopathy in four patients. J Clinical Rheumatol 14: 30-33, 2008
Moore TL: Juvenile idiopathic arthritis. In: “Conn’s Current Therapy”, (eds) RE Rake, ET Bope, pp 961-964, 2008
Syed RH, Gilliam BE, Moore TL: Rheumatoid factors and anti-cyclic citrullinated peptide antibodies in pediatric rheumatology. Curr Rheum Reports 10: 156-163, 2008
Moore TL: Systemic lupus erythematosus. In: “Internal Medicine: Just the Facts”, (eds) PG Schmitz, DD Miller, K Martin, pp 758-762, 2008
Moore TL: Rheumatoid arthritis. In: “Internal Medicine: Just the Facts”, (eds) PG Schmitz, DD Miller, K Martin, pp 768-772, 2008
Syed RH, Gilliam BE, Moore TL: Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 67: in press, 2008
Gilliam BE, Chauhan AK, Low JM, Moore TL: Measurement of biomarkers in juvenile idiopathic arthritis patients and their predication of disease severity: a comparative study. Clin Exp Rheumatol 26: in press, 2008
Moore TL: Autoimmunity and minocycline (Editorial). J Pediatr: in press, 2008
Low JM, Chauhan AK, Gibson DS, Zhu M, Chen S, Rooney ME, Moore TL: Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease associated proteins. Submitted for publication
Moore TL: Juvenile idiopathic arthritis. In: “Conn’s Current Therapy”, (eds) RE Rakel, ET Bope, pp in press, 2009